Corrigendum: Targeting the fibroblast growth factor receptor 2 in gastric cancer: Promise or pitfall? [Ann Oncol., 28, (2017) (1207-1216)] DOI: 10.1093/annonc/mdx081

C. Hierro; M. Alsina; M. Sánchez; V. Serra; J. Rodon; J. Tabernero

doi:10.1093/annonc/mdx800

Corrigendum: Targeting the fibroblast growth factor receptor 2 in gastric cancer: Promise or pitfall? [Ann Oncol., 28, (2017) (1207-1216)] DOI: 10.1093/annonc/mdx081

C. Hierro, M. Alsina, M. Sánchez, V. Serra, J. Rodon, J. Tabernero

Investigational Cancer Therapeutics

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Abstract

Dr. Rodon has been granted by Instituto de Salud Carlos III (ISCIII) with the project reference number PI15/00360, which has been selected as part of an operational program co-financed by the European Regional Development Fund (ERDF).

Original language	English (US)
Pages (from-to)	1605
Number of pages	1
Journal	Annals of Oncology
Volume	29
Issue number	7
DOIs	https://doi.org/10.1093/annonc/mdx800
State	Published - Jul 1 2018

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdx800

Cite this

@article{7c852ea248724954975ef537b1a91765,

title = "Corrigendum: Targeting the fibroblast growth factor receptor 2 in gastric cancer: Promise or pitfall? [Ann Oncol., 28, (2017) (1207-1216)] DOI: 10.1093/annonc/mdx081",

abstract = "Dr. Rodon has been granted by Instituto de Salud Carlos III (ISCIII) with the project reference number PI15/00360, which has been selected as part of an operational program co-financed by the European Regional Development Fund (ERDF).",

author = "C. Hierro and M. Alsina and M. S{\'a}nchez and V. Serra and J. Rodon and J. Tabernero",

year = "2018",

month = jul,

day = "1",

doi = "10.1093/annonc/mdx800",

language = "English (US)",

volume = "29",

pages = "1605",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "7",

}

TY - JOUR

T1 - Corrigendum

T2 - Targeting the fibroblast growth factor receptor 2 in gastric cancer: Promise or pitfall? [Ann Oncol., 28, (2017) (1207-1216)] DOI: 10.1093/annonc/mdx081

AU - Hierro, C.

AU - Alsina, M.

AU - Sánchez, M.

AU - Serra, V.

AU - Rodon, J.

AU - Tabernero, J.

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Dr. Rodon has been granted by Instituto de Salud Carlos III (ISCIII) with the project reference number PI15/00360, which has been selected as part of an operational program co-financed by the European Regional Development Fund (ERDF).

AB - Dr. Rodon has been granted by Instituto de Salud Carlos III (ISCIII) with the project reference number PI15/00360, which has been selected as part of an operational program co-financed by the European Regional Development Fund (ERDF).

UR - http://www.scopus.com/inward/record.url?scp=85051544658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051544658&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdx800

DO - 10.1093/annonc/mdx800

M3 - Comment/debate

C2 - 29300805

AN - SCOPUS:85051544658

SN - 0923-7534

VL - 29

SP - 1605

JO - Annals of Oncology

JF - Annals of Oncology

IS - 7

ER -

Corrigendum: Targeting the fibroblast growth factor receptor 2 in gastric cancer: Promise or pitfall? [Ann Oncol., 28, (2017) (1207-1216)] DOI: 10.1093/annonc/mdx081

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this